2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow HSIL: new trials by email Literature Review of HSIL trials Research Report on HSIL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) VGX-3100, Matched Placebo, CELLECTRA™-5PSP - Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion | Phase 3 | Completed | Inovio Pharmaceuticals | 203 | 2019-02-28 | 2024-10-17 |
| REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) VGX-3100, Placebo, Electroporation (EP) - Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion | Phase 3 | Completed | Inovio Pharmaceuticals | 201 | 2017-06-28 | 2023-07-27 |
Squamous Intraepithelial Lesions (2) · Uterine Cervical Dysplasia (2)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Morphological and Microscopic Findings (2) · Neoplasms (2) · Pathological Conditions, Signs and Symptoms (2) · Precancerous Conditions (2) · Urogenital Diseases (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2)
VGX-3100 (2) · Electroporation (1)
Argentina (2) · Estonia (2) · Finland (2) · Lithuania (2) · Poland (2) · Puerto Rico (2) · South Africa (2) · Spain (2) · United States (2) · Belgium (1) · Brazil (1) · Germany (1) · Italy (1) · Mexico (1) · Peru (1)
2016 (1), 2018 (1)